| Book Review | The Journal of American History, 92.2

You have not been recognized as a subscriber to JAH online. About 184 words from this article are provided below; about 367 words remain.

If you are a individual member of the Organization of American Historians, you may:: • login here if you have already registered for online access.; • Or if you're already logged in register your subscription.
• Set up your online account for the first time.
If you are not a member of the Organization of American Historians, you can:: • Join the OAH and receive many member benefits including print and electronic issues of the Journal of American History.
• Purchase a research pass to gain two-hour access to the entire History Cooperative web site. You will have full access to current issues of the Journal of American History (86.1-present). Note: the Research Pass does not provide access to JSTOR's holdings of the Journal of American History.
Instititutions can:: • Subscribe to this journal and receive print and electronic issues.
• Activate your existing subscription so that we recognize your IP number ranges.

| Book Review | The Journal of American History, 92.2 | The History Cooperative

Book Review

Pain and Profits: The History of the Headache and Its Remedies in America. By Jan R. Mc-Tavish. (New Brunswick: Rutgers University Press, 2004. x, 239 pp. Cloth, $62.00, ISBN 0-8135-3440-2. Paper, $23.95, ISBN 0-81353441-0.)

Pain and Profits is an accessible social history of headache that aims to answer the question of why headache treatment remains in popular hands. It is also a highly readable history of jurisdictional disputes among the pharmaceutical industry, dispensing druggists, and clinical practitioners that is suitable for undergraduate courses. Bringing the history of drug supply (and demand) to bear upon the history of headache, Jan R. McTavish interweaves the history of commerce with the history of medicine. She uses patient accounts of this most everyday complaint to supplement those of the trade press, which portray ongoing professional disputes over prescription, distribution, advertising, and marketing but largely ignore sufferers. The book is also a history of intellectual property and direct-to-consumer pharmaceutical advertising, a much-contested policy blamed for everything from the commodification of medicine to its democratization. This book reminds us that both are far from new phenomena.

. . .

There are about 367 more words in this article. Please log in (or, if you are not yet an authorized user, please go to the User Setup page) to gain full access rights. Or if you're already logged in register your subscription.